Methyl-β-cyclodextrin restores impaired autophagy flux in Niemann-Pick C1-deficient cells through activation of AMPK

The drug 2-hydroxypropyl-β-cyclodextrin (HPβCD) reduces lysosomal cholesterol accumulation in Niemann-Pick disease, type C (NPC) and has been advanced to human clinical trials. However, its mechanism of action for reducing cholesterol accumulation in NPC cells is uncertain and its molecular target i...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Sheng, Dulcey, Andrés E., Hu, Xin, Wassif, Christopher A., Porter, Forbes D., Austin, Christopher P., Ory, Daniel S., Marugan, Juan, Zheng, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Translational Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584846/
https://www.ncbi.nlm.nih.gov/pubmed/28613987
http://dx.doi.org/10.1080/15548627.2017.1329081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584846/
https://www.ncbi.nlm.nih.gov/pubmed/28613987
http://dx.doi.org/10.1080/15548627.2017.1329081

Ejemplares similares